Title : ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer.

Pub. Date : 2011 Feb

PMID : 21093896






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSIONS: The ERCC1 expression patterns in pretreatment specimens may thus facilitate the prediction of responses to cisplatin-based NAC. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 We propose that patients expressing low levels of ERCC1 derive the most benefit from cisplatin-based NAC. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens